Peter D. Reaven

Internal Medicine

650 E Indian School Rd
Phoenix, AZ 85012

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Independent Genetic Effects of Glucagon-like Peptide-1 Receptor Locus on Body Mass Index and Type 2 Diabetes.

Independent Genetic Effects of Glucagon-like Peptide-1 Receptor Locus on Body Mass Index and Type 2 Diabetes.

Journal: medRxiv : the preprint server for health sciences

Published: May 01, 2026

Continuous Glucose Monitoring (CGM) Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration.

Continuous Glucose Monitoring (CGM) Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration.

Journal: Diabetes care

Published: March 04, 2026

Association of Continuous Glucose Monitoring Metrics with Incident Diabetic Retinopathy: A Real-World Long-Term Study.

Association of Continuous Glucose Monitoring Metrics with Incident Diabetic Retinopathy: A Real-World Long-Term Study.

Journal: Diabetes technology & therapeutics

Published: January 23, 2026

Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of Energy.

Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of Energy.

Journal: Journal of the American Medical Informatics Association : JAMIA

Published: January 21, 2026

Digital phenotyping of CGM engagement reveals distinct glycemic outcomes.

Digital phenotyping of CGM engagement reveals distinct glycemic outcomes.

Journal: PLOS digital health

Published: January 12, 2026

Dynamically predicting renal failure after development of diabetes across biobanks.

Dynamically predicting renal failure after development of diabetes across biobanks.

Journal: PLOS digital health

Published: November 24, 2025

Obesity and overweight-related differences in cardiometabolic risk factors in type 1 diabetes.

Obesity and overweight-related differences in cardiometabolic risk factors in type 1 diabetes.

Journal: Diabetes, obesity & metabolism

Published: August 01, 2025

Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetes.

Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetes.

Journal: Research square

Published: July 25, 2025

Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial.

Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial.

Journal: Diabetes, obesity & metabolism

Published: June 24, 2025

Initiation of Continuous Glucose Monitoring and Mortality in Type 2 Diabetes.

Initiation of Continuous Glucose Monitoring and Mortality in Type 2 Diabetes.

Journal: Diabetes technology & therapeutics

Published: May 28, 2025

Temporal Glycemic Patterns in Type 1 and Type 2 Diabetes: Insights From Extended Continuous Glucose Monitoring.

Temporal Glycemic Patterns in Type 1 and Type 2 Diabetes: Insights From Extended Continuous Glucose Monitoring.

Journal: Journal of diabetes science and technology

Published: May 25, 2025

Blood pressure variability is associated with heart failure risk, elevated NT-proBNP, and elevated high-sensitivity troponin: the Multi-Ethnic Study of Atherosclerosis.

Blood pressure variability is associated with heart failure risk, elevated NT-proBNP, and elevated high-sensitivity troponin: the Multi-Ethnic Study of Atherosclerosis.

Journal: American journal of hypertension

Published: May 13, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026